Sinovac Biotech, Ltd
SVA
SVA was delisted on the 22nd of February, 2019.
37 hedge funds and large institutions have $66.5M invested in Sinovac Biotech, Ltd in 2015 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 7 closing their positions.
6% more capital invested
Capital invested by funds: $62.6M → $66.5M (+$3.95M)
8% less funds holding
Funds holding: 40 → 37 (-3)
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Manhattan
New York
|
+$3.19M |
| 2 |
Renaissance Technologies
New York
|
+$407K |
| 3 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
+$241K |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$161K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$127K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.65M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$539K |
| 3 |
Goldman Sachs
New York
|
-$296K |
| 4 |
Morgan Stanley
New York
|
-$167K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$121K |
SVA Hedge Fund Activity: Q2 2015 in Review
37 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Sinovac Biotech, Ltd (SVA) for Q2 2015, worth a combined $66.5M — up 6.3% from $62.6M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of SVA and 5 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 10 added.
The largest buyer was First Manhattan, opening a new position worth an estimated $3.19M. The largest seller was Wellington Management Group, cutting an estimated $2.65M.
- 37 institutional investors held Sinovac Biotech, Ltd (SVA) as of Q2 2015, down from 40 in Q1 2015.
- Funds reported $66.5M of Sinovac Biotech, Ltd stock for Q2 2015, up 6.3% quarter-over-quarter.
- 5 funds opened new Sinovac Biotech, Ltd positions in Q2 2015 and 7 closed out, a net change of -2 holders.
- The largest Sinovac Biotech, Ltd buyer in Q2 2015 was First Manhattan, an estimated $3.19M added.
- The largest Sinovac Biotech, Ltd seller in Q2 2015 was Wellington Management Group, an estimated $2.65M sold.
Based on aggregated 13F filings for Q2 2015.